Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
ANDE develops Rapid DNA technology, providing mobile and ruggedized systems that let field teams perform DNA analysis on-site. The equipment is designed for rapid integration of DNA testing into operational workflows outside of traditional laboratory settings.
0 investors
0 investors
Andon Bio is a spinout from the University of Colorado School of Medicine developing aa-tRNA-seq, a molecular biology method for studying protein translation and tRNA aminoacylation. The company builds experimental and computational tools for research into cellular translation mechanisms.
0 investors
0 investors
0 investors
0 investors
0 investors
Angarus Therapeutics was a biotechnology company. It is no longer operating.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Animerra develops next-generation biologics for companion animal health, applying therapeutic innovation from human medicine to veterinary treatment. The company targets pet owners and veterinary markets with innovative protein-based therapeutics and biologics treatments.
0 investors
Anivive develops new medicines for companion animals, using software across the drug development process to accelerate the creation of treatments. It serves the animal health community, focusing on veterinary and pet health pharmaceuticals.
0 investors
Ankasa is developing ART352-L, a regenerative medicine designed to enhance bone formation in reconstructive surgeries, with initial focus on spinal fusion procedures to treat degenerative disc disease. The therapy aims to improve healing outcomes and reduce revision surgeries for patients requiring bone reconstruction.
0 investors
0 investors
0 investors
0 investors
Antidote Therapeutics is a biotechnology company focused on drug discovery and development, led by an experienced team with backgrounds in clinical trials, pharmaceutical development, and biomarker-driven innovation.
0 investors
0 investors
Antlia Bioscience develops long-acting therapeutics aimed at treating chronic cardiometabolic diseases.
0 investors